Ad
related to: nmda receptor
Search results
Study models how ketamine's molecular action leads to its effects on the brain
Medical Xpress· 1 hour agoA World Health Organization Essential Medicine, ketamine is widely used at varying doses for sedation, pain control, general anesthesia and as a therapy for treatment-resistant depression. While ...
Beyond Traditional Diet Pills: Groundbreaking New Weight Loss Drug Is More Effective Than Current...
SciTechDaily· 2 days agoA revolutionary study published in Nature introduces a new obesity treatment that surpasses the...
GLP-1-directed NMDA receptor antagonism for obesity treatment - Nature
Nature· 6 days agoUnimolecular integration of NMDA receptor antagonism with GLP-1 receptor agonism effectively reverses obesity, hyperglycaemia and dyslipidaemia in rodent models of metabolic disease.
Biohaven Ltd. (NYSE:BHVN) Director John W. Childs Purchases 28,500 Shares of Stock
ETF DAILY NEWS· 6 days agoBiohaven Ltd. (NYSE:BHVN – Get Free Report) Director John W. Childs purchased 28,500 shares of Biohaven stock in a transaction dated Monday, May 13th. Following the completion of the acquisition ...
Experimental obesity drug packs double punch to reduce weight
Nature· 7 days agoTest of weight-loss candidate in mice shows that there is still room for improvement in a burgeoning...
Dual-action obesity drug rewires brain circuits for appetite
Nature· 7 days agoTwo-in-one drug better than GLP-1 agonist alone at inducing weight loss.
Inhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in vivo - Molecular...
Nature· 3 days agoAutism Spectrum Disorders (ASD) comprise a range of early age-onset neurodevelopment disorders with genetic heterogeneity. Most ASD related genes are involved in synaptic function, which is ...
Mira Pharmaceuticals progresses Ketamir-2 preclinical trials By Investing.com
Investing.com· 23 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a pre-clinical-stage pharmaceutical company, announced...
Forget Ozempic: There could be an even more effective weight-loss drug on the way
Fast Company Magazine· 4 days agoA new paper released in Nature this week discusses a new therapy for obesity that researchers say leads to more weight loss in mice than existing GLP-1 weight-loss medications, such as Ozempic ...
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2,...
Loudoun Times-Mirror· 1 day agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced ...
